BOSTON - Seaport Therapeutics, a clinical-stage biopharmaceutical company, has published new research demonstrating significant advancements in drug delivery through the lymphatic system using its ...

A possible explanation is differences in first-pass metabolism among individual subjects. Some of the variability after rectal administration may be related to the site of absorption within the ...